Last reviewed · How we verify

NCT04758390: IMARA-SA

A Comprehensive HIV Prevention Package for South African Adolescent Girls and Young Women

Completed NA Last updated 20 January 2025
What this trial tests

NA trial testing IMARA (intervention group) in Sexually Transmitted Infections in 1,290 participants. Completed in 4 October 2024.

Timeline
2 October 2021
Primary endpoint
7 April 2024
4 October 2024

Quick facts

Lead sponsorUniversity of Illinois at Chicago
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment1,290
Start date2 October 2021
Primary completion7 April 2024
Estimated completion4 October 2024
Sites1 location across South Africa

Drugs / interventions tested

Conditions studied

Sponsor

University of Illinois at Chicago

Who can join

Adults 15 to 19, female only, with Sexually Transmitted Infections or HIV Infections. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To achieve an AIDS-free generation, there is a critical need for programs which go beyond individual-level behavior change to reduce HIV and STI infections among adolescent girls and young women in sub-Saharan Africa. Informed, Motivated, Aware, and Responsible Adolescents and Adults (IMARA) is an evidence-based HIV-prevention intervention for adolescent girls and young women (AGYW) and their female caregivers, which has been adapted for a South African audience. The study will test whether AGYW receiving IMARA will have fewer sexually-transmitted infections (STI) and greater acceptance of HIV testing and counseling (HTC) and pre-exposure prophylaxis (PrEP) at 6-month follow-up compared to AGYW assigned to the health-promotion control intervention.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Mental health outcomes of a pilot 2-arm randomized controlled trial of a HIV-prevention program for South African adolescent girls and young women and their female caregivers.
    Donenberg G, Merrill KG, Atujuna M, Emerson E, et al · · 2021 · cited 11× · PMID 34847908 · DOI 10.1186/s12889-021-12010-1
  2. Integrating Adolescent Mental Health into HIV Prevention and Treatment Programs: Can Implementation Science Pave the Path Forward?
    Boshe J, Brtek V, Beima-Sofie K, Braitstein P, et al · · 2023 · cited 6× · PMID 36322219 · DOI 10.1007/s10461-022-03876-2
  3. An individually randomized controlled trial of a mother-daughter HIV/STI prevention program for adolescent girls and young women in South Africa: IMARA-SA study protocol.
    Donenberg GR, Atujuna M, Merrill KG, Emerson E, et al · · 2021 · cited 6× · PMID 34544403 · DOI 10.1186/s12889-021-11727-3

Verify or expand the search:

Other recruiting trials for Sexually Transmitted Infections

Currently open trials in the same condition.

Other University of Illinois at Chicago trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04758390.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing